Posts by Sandra Ansanay-Alex
Clee Medical, ProSeed & Berninox Shine at the 2025 >>venture>> Awards
The 2025 >>venture>> Award Ceremony at ETH Zurich brought together the brightest minds of Swiss innovation, with nearly 400 startups submissions and 18 finalists celebrated across six verticals. Among the standout innovators, three Swiss Health Valley startups were awarded. In the Health & Nutrition category, Clee Medical SA, a Geneva-based, Wyss Center spinoff, earned…
Read More10th Patient Quality of Life Challenge: Five Innovative Projects Awarded
For its 10th edition, the Patient Quality of Life Challenge reaffirmed its role as a launch pad for innovation in healthcare. Five finalists were selected out of more than 150 applications. Driven by Debiopharm, La-Solution.ch, and the Inartis Foundation, the Patient Quality of Life Challenge attracted nearly 150 submissions this year. Five finalists were…
Read MoreTerapet Achieved ISO 13485:2016 certification for its Quality Management System
Terapet’s is a Geneva-based, CERN spinoff, whose proprietary technology is designed to enhance precision in nuclear medicine and radiation therapy by providing advanced imaging and radiation verification solutions. The company is currently developing systems intended to support improved diagnostic accuracy and treatment outcomes in oncology and beyond. “This certification provides a solid foundation as…
Read MoreEAN Congress
The 13th European Academy of Neurology congress will be on 12-15 June 2027, in Gothenburg, Sweden In 2027, the EAN Congress is exploring the frontiers of treatment in neurology with the Overarching Theme Transforming Neurology: Embracing Every Brain. Where once treatment options for many neurological disorders were limited to supportive care, advances in neuroscience have driven the…
Read MoreWomen in Life Sciences in the Swiss Health Valley
The Swiss Health Valley continues to shine, thanks to the talent, leadership, and vision of extraordinary women shaping the future of medicine and science. Prof. Sophie Pautex, Head of the Department of Rehabilitation and Geriatrics and Chief Physician of the Palliative Care Service at the HUG, has received the EAPC Clinical Impact Award…
Read MoreKYLYS AESTHETICS SA secures CHF 1 Million
The Geneva-based startup and FONGIT alumni develops next-generation hyaluronic acid-based medical devices. KYLYS AESTHETICS SA, a Swiss biotech clinical stage company pioneering high-performance regenerative aesthetic solutions, proudly announces the successful closing of a CHF 1 million fundraising round by existing and new investors. This capital injection will allow the company to advance the development and…
Read MoreMyriad Optics Raises CHF 150’000 from Venture Kick
The EPFL spin-off develops new and disruptive bacterial contamination detection tools that can revolutionize food testing. Testing delays lasting hours to days cost companies millions and expose consumers to health risks. Myriad Optics’ technology targets faster detection to prevent costly recalls and protect public safety. In the food, pharma, and medtech sectors, delays in…
Read MoreSwiss Technology Award
Apply before 14 August 2026 for the Swiss Technology Award Innovation is the key driver of Switzerland’s economy, ensuring its prosperity. The presentation of the Swiss Technology Award supports and promotes this culture of innovation. Each year, outstanding technology-based innovations and developments from start-ups, universities and technical institutions as well as established businesses are awarded…
Read MoreClee Medical Wins a W.A. De Vigier Award
Clee Medical, a Wyss Center for Bio and Neuroengineering Geneva spinoff, wins a W.A. De Vigier Award worth CHF 120’000 Clee Medical, a Geneva-based medtech startup, is transforming brain surgery with an advanced platform that combines ultra-high-resolution real-time imaging, AI-based navigation, and machine learning. This technology allows surgeons to operate with extreme precision, reducing…
Read MoreOdne, an EPFL and ETHZ spinoff, raises CHF 4,2 Million in Series A
Odne’s story began through a close collaboration between leading researchers at EPFL and ETHZ, who sought to address long-standing clinical challenges in endodontic therapy. With over CHF 4.2 million raised in its Series A1 round — including support from ZEISS Ventures — and several FDA-cleared products now entering the U.S. market, the medtech company is…
Read More